Publication | Closed Access

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

Chemotherapy-induced NauseaMedicinePharmacologyGynecologyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyGynecology OncologyOvarian Cancer